Trial intelligence / Profile preview

Idebenone in Friedreich's Ataxia

NCT00537680Phase 3Completed

Sponsor
Santhera Pharmaceuticals
Start
Dec 2007
Primary completion
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of idebenone in Friedreich's ataxia (FA), sponsored by Santhera Pharmaceuticals. Started Dec 2007; status: completed.

02

Drugs

idebenone
03

Conditions

Friedreich's ataxia (FA)

Beyond the preview

Go deeper on NCT00537680.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00537680.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call